Biora Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Biora Therapeutics

15/08/2022 22:01

* Biora Therapeutics Inc  BIOR.OQ  reported a quarterly
adjusted
loss of 3 cents​​ per share for the quarter ended in June. The
mean expectation of two analysts for the quarter was for a loss
of 12 cents per share.
    * Revenue fell 77.5% to $104.00 thousand from a year ago;
analysts
expected zero. 
    * Biora Therapeutics Inc's reported EPS for the quarter was
a loss
of 3 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Biora Therapeutics Inc shares had risen by 42.9% this
quarter and lost 52.2% so far this year.
    * The company reported a quarterly loss of $5.51 million.
    * Wall Street's median 12-month price target for Biora
Therapeutics Inc is $5.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 15
at 09:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.12          -0.03          Beat
 Mar. 31 2022      -0.12          -0.08          Beat
 Dec. 31 2021      -0.16          -0.56          Missed
 Sep. 30 2021      -0.45          -0.46          Missed